After 22 years of working and studying abroad, Dr AraÃºjo shares his perspective of the biopharma industry in Latin America from both inside and outside of the region. He writes about how the insiders see international investors and what are the pros and cons for those interested in exploring LatAm biopharmaceutical markets.
Stronger democracies, decreased inflation and increased income transformed the purchasing power and capitalist mind frame of the population, which in return is empowering consumption. This combined with specific regulatory landmarks and universal health care systems have all played their part in the growing pharmaceutical markets in Latin America, particularly in Brazil, Mexico and Argentina.
To read the full whitepaper, click here.